Reference
FDA. FDA Alerts Patients and Health Care Professionals to Nitrosamine Impurity Findings in Certain Metformin Extended-Release Products. Internet Document : 28 May 2020. Available from: URL: https://www.fda.gov/news-events/press-announcements/fda-alerts-patients-and-health-care-professionals-nitrosamine-impurity-findings-certain-metformin
Rights and permissions
About this article
Cite this article
Metformin extended-release products recalled in USA. Reactions Weekly 1807, 4 (2020). https://doi.org/10.1007/s40278-020-79290-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-79290-y